Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/49344
Título: Improving the diagnosis of cobalamin and related defects by genomic analysis, plus functional and structural assessment of novel variants
Autores/as: Brasil, Sandra
Leal, Fátima
Vega, Ana
Navarrete, Rosa
Ecay, María Jesús
Desviat, Lourdes R.
Riera, Casandra
Padilla, Natàlia
De La Cruz, Xavier
Couce, Mari Luz
Martin-Hernández, Elena
Morais, Ana
Pedrón, Consuelo
Peña-Quintana, Luis 
Rigoldi, Miriam
Specola, Norma
De Almeida, Isabel Tavares
Vives, Inmaculada
Yahyaoui, Raquel
Rodríguez-Pombo, Pilar
Ugarte, Magdalena
Pérez-Cerda, Celia
Merinero, Begoña
Pérez, Belén
Clasificación UNESCO: 320102 Genética clínica
Palabras clave: Methylmalonic Aciduria
Inborn Error
Vitamin-B-12 Metabolism
Sequence Variants
B-12 Trafficking, et al.
Fecha de publicación: 2018
Publicación seriada: Orphanet Journal of Rare Diseases 
Resumen: Background: Cellular cobalamin defects are a locus and allelic heterogeneous disorder. The gold standard for coming to genetic diagnoses of cobalamin defects has for some time been gene-by-gene Sanger sequencing of individual DNA fragments. Enzymatic and cellular methods are employed before such sequencing to help in the selection of the gene defects to be sought, but this is time-consuming and laborious. Furthermore some cases remain undiagnosed because no biochemical methods have been available to test for cobalamin absorption and transport defects.Results: This paper reports the use of massive parallel sequencing of DNA (exome analysis) for the accurate and rapid genetic diagnosis of cobalamin-related defects in a cohort of affected patients. The method was first validated in an initial cohort with different cobalamin defects. Mendelian segregation, the frequency of mutations, and the comprehensive structural and functional analysis of gene variants, identified disease-causing mutations in 12 genes involved in the absorption and synthesis of active cofactors of vitamin B12 (22 cases), and in the non-cobalamin metabolism-related genes ACSF3 (in four biochemically misdiagnosed patients) and SUCLA2 (in one patient with an unusual presentation). We have identified thirteen new variants all classified as pathogenic according to the ACGM recommendation but four were classified as variant likely pathogenic in MUT and SUCLA2. Functional and structural analysis provided evidences to classify them as pathogenic variants.Conclusions: The present findings suggest that the technology used is sufficiently sensitive and specific, and the results it provides sufficiently reproducible, to recommend its use as a second-tier test after the biochemical detection of cobalamin disorder markers in the first days of life. However, for accurate diagnoses to be made, biochemical and functional tests that allow comprehensive clinical phenotyping are also needed.
URI: http://hdl.handle.net/10553/49344
ISSN: 1750-1172
DOI: 10.1186/s13023-018-0862-y
Fuente: Orphanet Journal of Rare Diseases [ISSN 1750-1172], v. 13: 125 (Julio 2018)
Colección:Artículos
miniatura
Adobe PDF (2,05 MB)
Vista completa

Citas SCOPUSTM   

2
actualizado el 14-abr-2024

Citas de WEB OF SCIENCETM
Citations

2
actualizado el 25-feb-2024

Visitas

45
actualizado el 15-oct-2022

Descargas

58
actualizado el 15-oct-2022

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.